Glenmede Trust’s Stevanato STVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$450K Sell
24,903
-13,558
-35% -$229K ﹤0.01% 1025
2026
Q1
$529K Buy
38,461
+8,770
+30% +$145K ﹤0.01% 944
2025
Q4
$597K Buy
+29,691
New +$690K ﹤0.01% 884
2025
Q1
$679K Buy
33,236
+635
+2% +$13.5K ﹤0.01% 808
2024
Q4
$710K Sell
32,601
-3,340
-9% -$66.9K ﹤0.01% 820
2024
Q3
$719K Buy
35,941
+4,050
+13% +$81.5K ﹤0.01% 820
2024
Q2
$585K Buy
31,891
+5,160
+19% +$120K ﹤0.01% 851
2024
Q1
$858K Buy
26,731
+8,570
+47% +$261K ﹤0.01% 750
2023
Q4
$496K Hold
18,161
﹤0.01% 895
2023
Q3
$540K Buy
18,161
+4,458
+33% +$140K ﹤0.01% 824
2023
Q2
$355K Hold
13,703
﹤0.01% 933
2023
Q1
$355K Sell
13,703
-170
-1% -$3.65K ﹤0.01% 938
2022
Q4
$249K Hold
13,873
﹤0.01% 1036
2022
Q3
$235K Buy
+13,873
New +$233K ﹤0.01% 1037

Other funds holding STVN

Glenmede Trust's STVN Position: Q2 2026 in Review

Glenmede Trust reduced its Stevanato (STVN) stake by 35% in Q2 2026, selling an estimated $229K and leaving 24,903 shares worth $450K. The position accounts for ﹤0.01% of the portfolio, ranked #1025.

Glenmede Trust first reported a position in STVN in Q3 2022 and has held it in 14 quarters since. The position peaked at $858K in Q1 2024. 125 funds tracked by Wall St. Rank hold STVN as of Q2 2026.

  • Glenmede Trust held 24,903 shares of Stevanato worth $450K as of Q2 2026.
  • Glenmede Trust sold 13,558 Stevanato shares in Q2 2026, an estimated $229K.
  • Stevanato made up ﹤0.01% of Glenmede Trust's portfolio in Q2 2026, its #1025 holding.
  • Glenmede Trust first reported a position in Stevanato in Q3 2022 and has held it in 14 quarters since.
  • Glenmede Trust's Stevanato position peaked at $858K in Q1 2024.
  • 125 funds tracked by Wall St. Rank held Stevanato as of Q2 2026.

Based on Glenmede Trust's 13F filing for Q2 2026, filed 10 Aug 2026.